Agoracom Blog Home

Archive for the ‘Next Gen’ Category

Next Gen Announces Successful Inaugural GreenRush Financial Conference in Vancouver; Invites Investors and Exhibitors to Attend the Upcoming Toronto Conference

Posted by AGORACOM-JC at 5:07 PM on Monday, May 26th, 2014

-The Inaugural Vancouver GreenRush Financial Conference exceeded expectations

-Over 1,200 attendees

-Over 35 exhibitors

-Expert speakers from across North America

-Media coverage from the major outlets across Canada

-The second conference is to be held in Toronto, Ontario on June 26, 2014 at the Metro Toronto Convention Centre North in the Constitution Hall

-Further conferences are also slated for Canada, the United States and Europe

-For further information and to register as an attendee please visit our websites at www.greenrushfinancialconferences.com and www.nextgenmetalsinc.com

GreenRush Financial Conferences is a wholly owned subsidiary of Next Gen (CSE-N, OTC-PK NXTTF, FSE-M5BN) and is aligned to be the Premier Purveyor of Investment Conferences for the Medical Marijuana, Industrial Hemp and Alternative Medicine Industries

-Management continues to receive and review numerous proposals including: alternative medicine, health, food, agri-business, legal grow-ops, science and technology, client generation, education, public awareness, specialty clinics and ancillary business opportunities throughout the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors

Vancouver, British Columbia, Canada / TNW-ACCESSWIRE / May 26, 2014 / Next Gen Metals Inc. (“Next Gen”, the “Company”) (CSE: N, OTC Pink: NXTTF, FSE: M5BN) is pleased to announce that its inaugural Vancouver GreenRush Financial Conference exceeded expectations. Next Gen also formally invites interested investors, industry participants, stakeholders and exhibitors to our second GreenRush Financial Conference in Toronto, Ontario on June 26, 2014.

Jay Oness, COO, stated that, “We are thrilled with the results of the inaugural Vancouver GreenRush Financial Conference. We would like to thank the 35+ exhibitors, 1200+ attendees and industry expert speakers from around the world that came together to make this conference the success that it was. We look forward to hosting our second GreenRush Financial Conference in Toronto, Ontario on June 26, 2014. We anticipate that the second show will be even bigger and better than the first.”

If you are interested in being a speaker, exhibitor or sponsor for the Toronto Conference please submit your indication of interest as soon as possible to the GreenRush Financial Conference team as it is selling out quickly.

For more information on GreenRush Conferences please visit our website at

www.greenrushfinancialconferences.com, email our Conference Coordinators (see below)

Or contact us by phone at (604) 685-1870

Conference Coordinators

Taylor Duncan-Barr – [email protected]

Ray Rich – [email protected]

Ray Lagace – [email protected]

About Next Gen

(CSE: N, OTC Pink: NXTTF, FSE: M5BN)
Next Gen is a diversified Canadian public company which focuses on investing in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. Recent regulatory/legal changes in North America have provided an opportunity for the company to enter into this emerging multi-billion dollar industry.
Next Gen’s vision is to be the leading provider of venture capital, management expertise, education and a facilitator for this explosive new industry.

Next Gen’s business model generates new industry business proposals and plans on a continuous basis. To that end, Management is currently negotiating with a number of companies who are interested in entering into contractual arrangement to co-venture, co-finance, and option-joint venture on one or more of Next Gen’s large inventory of business opportunities and existing 100% owned companies and projects in these multi-billion dollar industries. For further information, visit our website at www.nextgenmetalsinc.com.

On March 20, 2014 Next Gen Metals announced that it has established its first wholly owned subsidiary, a Conference Division that intends to host Canada’s first conferences focused on business to business opportunities, investment and education in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. GreenRush Financial Conferences’ vision is to be the premier purveyor of investment conferences for the Medical Marijuana, Industrial Hemp and Alternative Medicine industries.
On May 6, 2014 Next Gen announced the establishment of its second wholly owned subsidiary GreenRush Analytical Laboratories Inc. GreenRush Analytical Laboratories Inc. will provide analytical testing to the cannabis industry by delivering customized solutions and accurate analytical results and ensure the health and safety of consumers. GreenRush Analytical Laboratories vision is to become a leading Laboratory company focused on servicing the legalized cannabis industry in North America.

In light of Next Gen’s vision, Management’s intention is to invest in a basket of companies within this growing industry. The company’s business model continues to generate new business plans and project submittals 24/7.

In light of Next Gen’s vision, Management is evaluating multiple new business plans and industry related proposals on an ongoing basis. Management continues to receive and review numerous proposals including: alternative medicine, health, food, agri-business, legal grow-ops, science and technology, client generation, education, public awareness, specialty clinics and ancillary business opportunities. The directors of Next Gen have given management the directive to identify core business opportunities and then to invest in a basket of companies within these emerging sectors.

Tel: +1 604 685 1870 Fax: +1 604 685 8045 Website: http://www.nextgenmetalsinc.com
650-555 West 12th Avenue, City Square, West Tower, Vancouver, B.C., Canada, V5Z 3X7
On behalf of the Board of Directors

“Jay Oness”

Jay Oness

COO

FORWARD LOOKING INFORMATION

This News Release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements.

Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com.

This News Release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

The CSE has neither reviewed nor approved the contents of this News Release.

Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Toronto’s First Financial Investment Conference focused on Medical Marijuana, Industrial Hemp and Alternative Medicine Industries – June 26, 2014

Posted by AGORACOM-JC at 12:35 PM on Friday, May 23rd, 2014

YOU ARE INVITED TO ATTEND

Toronto GreenRush Financial Conference

WHEN June 26, 2014 7:30 a.m. – 6:00 p.m.
WHERE Metro Toronto Convention Centre, Level 100 Constitution Hall
TICKETS Register Online

The conference will feature insightful speakers from a diverse cross section within the above mentioned sectors including government, public and private companies, fund managers, bankers, brokers, investors, lawyers, accountants, analysts, and media representing all aspects of these industries we represent.

VISION: To be the Premier Purveyor of Investment Conferences for the Medical Marijuana, Industrial Hemp and Alternative Medicine Industries.

MISSION: To provide a platform/hub to facilitate investment, education and business to business opportunities across the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors.

GreenRush Financial Conferences is 100% owned by Next Gen Metals Inc. (Next Gen, CSE:N)

After an extremely successful Vancouver conference, May 7, 2014, GreenRush Financial Conferences will be in Toronto on June 26, 2014.

FUTURE CONFERENCES:
CANADA, UNITED STATES AND EUROPE (TO BE ANNOUNCED)

Interested parties or companies wishing to attend the conference can register online by visiting www.greenrushfinancialconferences.com by phone 604.685.1870 Toll Free 1.800.667.1870
For further information on GreenRush Financial Conferences and to book a trade booth, please contact the following people listed below:
Taylor Duncan-Barr [email protected] 604 648.1405
Ray Rich [email protected] 604 648.1401
Ray Lagace [email protected] 604.648.1413

Recent Articles – Interviewskkjksd

About Next Gen Metals Inc., a diversified public company focused on providing financial solutions for the Medical Marijuana, Industrial Hemp and Alternative Medicine Industries.(CSE: N, OTC Pink: NXTTF, FSE: M5BN)
  • VISION: To be a Leading provider of venture capital, management expertise, education and a facilitator for this explosive new industry
  • MISSION: To Provide Financial Solutions for the Medical Marijuana, Industrial Hemp and Alternative Medicine Industries. Recent regulatory and legal changes in North America have aided Next Gen in accomplishing its mission in these emerging multi-billion dollar industries
  • NEXT GEN’S BUSINESS MODEL: Generates new industry business proposals and plans on a continuous basis. To that end, Management is currently negotiating with a number of companies who are interested in entering into contractual arrangement to co-venture, co-finance, and option-joint venture on one or more of Next Gen’s large inventory of business opportunities and existing 100% owned companies and projects in these multi-billion dollar industry.

GreenRush Analytical Laboratories (GAL)
A wholly owned Subsidiary of Next Gen

  • VISION: To become a leading Laboratory company focused on servicing the legalized cannabis industry in North America.
  • MISSION: To provide analytical testing for the Legal Cannabis Industry in North America by delivering customized solutions and accurate analytical results to our clients.

Recently proposed Canadian Medical Marijuana and Industrial Hemp laws and regulations are anticipated to set additional standards for licensed producers that require more detailed Quality control and Quality assurances from Licensed Producers. GAL is organizing a team of scientists and laboratory technicians to staff our first laboratory. Simultaneously GAL’s management continues to meet with targeted under-funded Analytical Laboratory opportunities for possible mergers and acquisitions.

Management is currently in the process of assessing and selecting initial locations and jurisdictions to establish the laboratories. Management’s objective is to initiate analytical laboratories in areas with the greatest concentration of Licensed Producers in both the legal Medical Marijuana and Industrial Hemp industries.


Next Gen is evaluating multiple new business plans and industry related proposals on an ongoing basis. Management continues to receive and review numerous proposals including: alternative medicine, health, food, agri-business, legal grow-ops, science and technology, client generation, education, public awareness, specialty clinics and ancillary business opportunities. The directors of Next Gen have given management the directive to identify core business opportunities and then to invest in a basket of companies within these emerging sectors.

Toddler’s seizures stopped after consuming cannabis oil, parents say

Posted by AGORACOM-JC at 10:50 AM on Thursday, May 22nd, 2014

JUSTIN GIOVANNETTI

VANCOUVER — The Globe and Mail

Last updated Tuesday, May. 20 2014, 8:05 PM EDT

Two-year-old Kyla Williams hasn‘t learned to walk or talk, her development has stopped as she suffered as many as 200 seizures daily and no medication helped. Now the girl’s family say she hasn’t had a seizure in a week, ever since they began giving her cannabis oil extracted from hemp. (handout from family)

Two-year-old Kyla Williams hasn’t learned to walk or talk, her development has stopped as she suffered as many as 200 seizures daily and no medication helped. Now the girl’s family says she hasn’t had a seizure in a week, ever since they began giving her cannabis oil extracted from hemp.

The oil being used by the toddler has high amounts of cannabidiol, known as CBD, the main ingredient in medical marijuana, and almost no psychoactive ingredients. Its use is in a legal “grey area,” according to proponents.

Only dried marijuana is currently regulated by Health Canada, the sale of resin and oil by growers is forbidden. The hemp that the cannabis oil is being extracted from is supposed to be destroyed by farmers under federal regulations. However, few controls seem to govern the dispensary and parents providing the two-year-old with the oil.

Despite the lack of legal clarity, Kyla is continuing to use her unconventional medicine. On Sunday evening, she had been seizure-free for a week.

“Within 20 minutes of administering it the first time, she stopped her seizures completely. She had six seizures earlier as I said goodbye to her, it was so hard to watch,” said grandmother Elaine Nuessler.

On Saturday, the girl’s grandfather spoke publicly about the need for greater access to the medical marijuana-like substance. A former RCMP officer, Chris Nuessler told a crowd of 60 in Summerland, B.C. that his views on marijuana have changed significantly since his granddaughter began showing signs of uncontrollable epilepsy when she was six months old.

“We come from a background where we’ve never dealt with marijuana before in our lives,” said Ms. Nuessler. “We’ve discovered that it’s a healing plant.”

For more than a year, Kyla was treated with a battery of prescription drugs, none worked, many made her condition worse. Due to the epilepsy, the girl also suffers from serious visual impairments.

After being told by physicians that the girl’s life would be cut short by the seizures, the family contacted Jim Leslie at the Nation’s Best Weeds Society, a dispensary in Vancouver’s east end. Aided by anecdotal evidence that cannabis with high levels of CBD was being used successfully in the United States, Mr. Leslie set out to find something similar in Canada.

He soon came across an often discarded piece of hemp that is high in CBD. “We’ve got a winner here,” he remembers thinking when he saw the results of tests on the plant. “A small, small percentage of farmers are diverting the CBD-rich part of the plants to us,” said Mr. Leslie.

The Vancouver-based dispensary has a note from Kyla’s pediatric physician recommending cannabis. Under federal rules, the family should be providing the two-year-old with medical marijuana in it’s more traditional form.

In the past, Canadians have moved to the U.S. to gain access to the oil. In late 2013, the parents of 13-month-old Kaitlyn Pogson moved to Colorado to obtain the drug, hoping it would help with their daughter’s severe seizures.

With no medical trials showing that cannabis helps children with seizures, Arthur Schafer warned that the impact of the drug’s exposure on a child’s brain remains unknown.

“The rigorous scientific evidence isn’t there, but the anecdotal evidence seems quite promising. Would a reasonable and loving parent take the risk of giving their child medication that could cause serious harm? Not unless the situation is desperate and nothing else has worked,” said Mr. Schafer, the director of the Centre for Professional and Applied Ethics at the University of Manitoba.

“If the harm is there in front of you daily in seizures, the reasonable and loving parent might take the risk. I would.”

Follow Justin Giovannetti on Twitter: @justincgio

Source: http://m.theglobeandmail.com/news/british-columbia/toddlers-seizures-stopped-after-consuming-cannabis-oil-parents-say/article18769814/?service=mobile&cmpid=rss1&click=sf_globe

Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Pot Firms Gain as CVS, Walgreen Competition a Pipe Dream

Posted by AGORACOM-JC at 2:13 PM on Tuesday, May 13th, 2014
By Shannon Pettypiece and Sonali Basak May 13, 2014 12:01 AM ET

Photographer: Kathryn Scott Osler/The Denver Post via Getty Images

Kayvan Khalatbari, has poured $500,000 into pot production and $150,000 into a store, started in the industry by delivering medical marijuana door to door. This year, he expects sales of almost $2 million, which may rise to $5 million once he can also begin selling the drug commercially under Colorado law.

Americans seeking medical marijuana for anything from pain to seizures must turn to a patchwork of small startups for help as U.S. laws keep traditional pharmacies out of a market that may exceed $6 billion by 2019.

While more than 21 states have legalized pot for medicinal use, the drug remains illegal under federal law and banks are hesitant to accept money from its sale. That’s keeping drugstore chains CVS Caremark Corp. (CVS), Walgreen Co. and Rite Aid Corp. (RAD), out of the market, leaving local entrepreneurs in control.

“We aren’t going to see a big guy enter this market within the next few years,” said David Yang, an analyst with research firm IBISWorld. “There are just too many regulations and too many elements that make this impossible for them.”

In one state alone, Colorado, more than 400 companies are licensed as medical marijuana centers, with government officials predicting sales there could soon reach $1 billion. For Colorado businessman Kayvan Khalatbari, a former electrical engineer who started his business with just $4,000, federal limitations on the drug are a major benefit.

Khalatbari, who has poured $500,000 into pot production and $150,000 into a store, started in the industry by delivering medical marijuana door to door. This year, he expects sales of almost $2 million, which may rise to $5 million once he can also begin selling the drug commercially under Colorado law, he said.

“We’re making money, we’re employing people, we’re being a beacon of light for this industry and showing it can be done professionally,” Khalatbari said in a telephone interview. “That to me is a success.”

Federal Law

Traditional pharmacies, meanwhile, face a hurdle that keeps them from competing with entrepreneurs like Khalatbari. Even though almost half of states and the District of Columbia accept the drug’s use for medical purposes, marijuana isn’t deemed legal by the federal government. The drug is classified as a Schedule I controlled substance, defined as having a high potential for abuse with no accepted medical use.

The Legalization of Marijuana

Schedule 1 drugs, which includes heroin, can’t by law be prescribed or dispensed. Pharmacies must register with the U.S. Drug Enforcement Agency to dispense controlled substances, making it illegal for them to sell medical marijuana.

Walgreen, Rite Aid and CVS said in separate statements they have no plans to sell medical marijuana. Doing so, according to CVS spokeswoman Carolyn Castel, would violate the company’s registration with the DEA.

Tax Revenue

That may change if the U.S. Congress sees taxes on the drug as a way to raise money, said Brad Barker, an analyst with Bloomberg Industries in New York.

“The second this is legalized they will start rolling out the marijuana cigarettes the next day,” Barker said. “I think the same thing can be said with everything else. Then you’ll have all the big boys jumping into this space.”

More pharmacies would sell medical marijuana if drug companies created cannabis products that can be approved by federal regulators, like drugs or tobacco products, said Mark Kleiman, a professor of public policy at the University of California at Los Angeles School of Public Affairs.

“It’s not drug stores that have to make these decisions, its pharmaceutical companies that have to decide if they want to make cannabis products,” Kleiman said in a telephone interview. Eventually, that could fuel a “big threat to the medical dispensary business model.”

Existing Products

Existing pharmaceutical cannabis products include Marinol, a prescription pill made with synthetic cannabinoid for uses including treating nausea associated by chemotherapy, sold by AbbVie Inc. (ABBV), and Sativex, a spray form of marijuana produced by GW Pharmaceuticals Plc (GWP), a U.K.-based medical marijuana research and development company. Sativex isn’t available in the U.S.

Shareholders are already investing in publicly traded marijuana companies like GW Pharmaceuticals and Advanced Cannabis Solutions Inc. (CANN), a company that leases growing facilities to licensed growers and dispensaries. Barker said he’s tracking 160 public marijuana companies.

American depositary receipts for GW Pharmaceuticals have increased more than sevenfold in the past 12 months to $69.77, raising the company’s market capitalization to $1.24 billion. Shares of Colorado Springs, Colorado-based Advanced Cannabis Solutions, with a market value of about $210 million, has risen more than ninefold to $15.75.

New Investors

Next Gen Metals Inc. (N), a mineral exploration company, is among the investors preparing to put private capital into marijuana startups.

“You can certainly believe the large industries, the large pharmaceutical companies, that they’re looking into it,” Jay Oness, Next Gen’s chief operating officer, said. “When the time is right, I’m positive they’ll want to be a part of it either through acquisitions or by themselves.”

Until legalization or more products are marketed by pharmaceutical companies, it will be an industry dominated by small dispensaries set up to serve about 1.4 million medical marijuana cardholders using the drug to treat their symptoms.

Three states allow medical marijuana companies to make a profit from the sale of pot. The remaining 18 states that approve of the use of medical marijuana require distribution only by nonprofit organizations and cooperatives, according to the Marijuana Policy Project.

To contact the reporters on this story: Shannon Pettypiece in New York at [email protected]; Sonali Basak in New York at [email protected]

To contact the editors responsible for this story: Reg Gale at [email protected] Andrew Pollack

Source: http://www.bloomberg.com/news/2014-05-13/pot-firms-gain-as-cvs-walgreen-competition-a-pipe-dream.html

Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

GreenRush Financial Conferences Inc. Finalizes Speaker Lineup, Sells out Exhibits for May 7th Vancouver and Announces Toronto June 26th 2014

Posted by AGORACOM-JC at 10:31 AM on Tuesday, May 6th, 2014

GreenRush Financial Conferences is a wholly owned subsidiary of Next Gen (CSE-N, OTC-PK NXTTF, M5BN-FSE) and is aligned to be the Premier Purveyor of Investment Conferences for the Medical Marijuana, Industrial Hemp and Alternative Medicine Industries

-The first two Conferences are to be held in Vancouver and Toronto

-Vancouver, British Columbia – Wednesday May 7, 2014 at the Vancouver Convention and Exhibition Centre East in Ballrooms A/B/C

-Toronto, Ontario – Thursday June 26, 2014, at the Metro Toronto Convention Centre North in the Constitution Hall

-Further conferences are also slated for Canada, the United States and Europe

-The conference will highlight investments in health, agri-business, food, legal grow-ops, science and technology, client generation, education, public awareness, specialty and wellness clinics and auxiliary business opportunities throughout the Medical Marijuana, Industrial Hemp and Alternative Medicine industries including legalization vs prohibition and related cannabis misconceptions.

-The Vancouver Conference will feature “Industry Experts”, “Investment Experts”, “Corporate Presentations”, “Media Power Hour”, and “The Great Debate: Legalization vs. Prohibition and other related misconceptions “, followed by “A Party with a Purpose!!!”

-For further information and to register as an attendee please visit our websites at www.greenrushfinancialconferences.com and www.nextgenmetalsinc.com

Vancouver, British Columbia, Canada — (May 6, 2014) – Next Gen Metals Inc. (“Next Gen”, the “Company”) (CSE: N, OTC Pink: NXTTF, FSE: M5BN) is pleased to announce the final list of speakers and exhibitors at its inaugural GreenRush Financial Conference to be held in Vancouver, British Columbia on May 7th 2014. Next Gen is also pleased to announce that it has chosen Thursday, June 26th 2014 for its second GreenRush Financial Conference in Toronto, Ontario. GreenRush Financial Conferences objective is to provide a platform/hub to facilitate investment, education and business to business opportunities across the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors.

Harry Barr, President and CEO stated, “The Medical Marijuana, Industrial Hemp and Alternative Medicine industries all have the potential for exponential growth. Recent North American legislation has dramatically changed our industry’s ability to finance existing and new projects. With that in mind GreenRush Financial Conferences will act as a financial hub for these three emerging industries and will facilitate both education and investment across the industries. We look forward to hosting Canada’s first Medical Marijuana, Industrial Hemp and Alternative Medicine Investment conference in Vancouver, BC on May 7th, 2014 and our second conference in Toronto on June 26th 2014 at the Metro Toronto Convention Centre”

 

Vancouver GreenRush Exhibitors and Speakers (Subject to Change)

Sponsor List

Platinum Sponsor BC Chronic Inc. (TSX.V-AXO)
Party with a Purpose Sponsor

Coffee Sponsor

Signage Sponsor

Security Sponsor

Music Sponsor

Cannan Cannabis

Next Gen Metals Inc. (CSE-N,OTCPK- NXTTF, FSE-M5BN)

Thelon Ventures (THC.V)

Pacific Northwest Capital (TSX.V – PFN, OTCQB- PAWEF)

Southern Sun Minerals (TSX.V – SSJ, FSE-P73)

International Metals Group

Speaker List

Bruce Linton Tweed Marijuana Inc. Alan Schroepfer Akamai Acupuncture
Alan Brochstein 420 Investor Terry Roycroft MCRCI
Dr. Paul Hornby Hedron Analytical Anndrea Hermann Hemp Industries Association
John Conroy Conroy and Company Mike Withrow Abattis Bioceuticals Corp.
Chris Bunka Lexaria Corp. Kirk Tousaw Tousaw Law
Russ Crawford Canadian Hemp Trade Alliance Daniel Kiselbach Deloitte
Michael Martinz BC Chronic Inc. John Berfelo Next Gen Medical Advisor
Brian O’Dea BC Chronic Inc. Frank Lane Cannabis Financial Network
Harry Barr Next Gen Metals Inc. Victor Foia Greenplex Services Inc.
Chris Parry Stockhouse Marcus New InvestX Capital Ltd.
Ali Sinawi

Craig Goodwin

Market One Media

Naturally Splendid Enterprises

James Black

George Tsiolis

Canadian Securities Exchange

Agoracom

Bob Beaty VantageWire/Financial Press Jodie Emery Cannabis Culture
Marcus Richardson Freshheadies Ltd/Bubblebags Hugo Kotar Medical Marijuana Industry
Joy Davies Canadian Medical Cannabis Partners

Exhibitor List

420 Investor GreenPlex Services Inc. Pinnacle Digest
Abattis Bioceuticals Corp.

Agoracom

Greywood Partners

Hemp HoodLamb

Rango Energy Inc.

Satori Resources Inc.

Bayhorse Silver Inc.

BC Chronic Inc.

Hemp Industries Association

Investment Pitch

Singh Investment Partners

Stockhouse

Benton Capital Corp. InvestX Capital Ltd Supreme Pharmaceuticals Inc
Cannabis Investor International Metals Group The Bitcoin Co-Op
Cannabis Investment News

Canadian Medical Cannabis Partners

Canadian Securities Exchange

Jordan Capital Markets Inc.

Lexaria Corp.

Medicinal Cannabis Resource Centre

VantageWire/Financial Press Vitex Brokerage Ltd.

Wisplite Technologies Inc.

Crop King Seeds

Euro Pacific Canada

Medtainer Canada

Naturally Splendid Enterprises

ePuffer International Inc.

Wildflower Marijuana Inc.

Forever Green Next Gen Metals Inc. Wolrige Mahon
Pacific North West Capital

Please visit www.greenrushfinancialconferences.com
for more information on our speakers and exhibitors.

About GreenRush Financial Conferences

GreenRush Financial Conferences is a wholly owned subsidiary of Next Gen (PubCo, CSE: N, OTC Pink: NXTTF, FSE: M5BN). GreenRush’s vision is to be the premier purveyor of investment conferences for the Medical Marijuana, Industrial Hemp and Alternative Medicine industries.

The conference will feature insightful speakers, government, health and industry specialists, public and private companies, fund managers, bankers, brokers, analysts, and media who share a common interest in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. GreenRush Conferences will be tailored to institutional, high net worth and retail investors with a focus on education and investment in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors.

The first conference will held in Vancouver, British Columbia on Wednesday May 7th, 2014 at the Vancouver Convention and Exhibition Centre East in Ballrooms A/B/C. The second conference will be held in Toronto, Ontario on Thursday June 26, 2014 at the Metro Toronto Convention Centre North in the Constitution Hall. Further conferences are also slated for Canada, the United States and Europe.

 

Investors and other interested parties are invited to attend and learn about investing in the Medical Marijuana, Industrial Hemp and Alternative Medicine business sector

For more information on GreenRush Conferences please visit our website at

www.greenrushfinancialconferences.com, email us at [email protected] or contact us by phone at (604) 685-1870.

About Next Gen

(CSE: N, OTC Pink: NXTTF, FSE: M5BN)

Next Gen is a diversified Canadian public company which focusses on investing in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. Recent regulatory/legal changes in North America have provided an opportunity for the company to enter into this emerging multi-billion dollar industry. Next Gen’s Vision is to be the Leading Provider of Venture Capital for the Medical Marijuana, Industrial Hemp and Alternative Medicine Industries.

Next Gen’s business model generates new business plans and industry related proposals on an ongoing basis. Management continues to receive and review the proposals from various segments of the industry including: alternative medicine, health, food, agri-business, legal grow-ops, science and technology, client generation, education, public awareness, specialty and wellness clinics and ancillary business opportunities. For further information, visit our website at www.nextgenmetalsinc.com.

In light of Next Gen’s vision, Management’s objective is to invest in a basket of companies within this growing industry. The company’s business model continues to generate new business plans and project submittals 24/7.

For further information on GreenRush Financial Conferences please contact us by phone or at [email protected] or [email protected].

For further information and general Investor Relations Inquiries please contact us by phone or email at [email protected].

Tel: +1 604 685 1870 Fax: +1 604 685 8045 Website: http://www.nextgenmetalsinc.com
650-555 West 12th Avenue, City Square, West Tower, Vancouver, B.C., Canada, V5Z 3X7
On behalf of the Board of Directors

“Harry Barr”

Harry Barr

President & CEO

FORWARD LOOKING INFORMATION

This News Release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements.

Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com.

This News Release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

The CSE has neither reviewed nor approved the contents of this News Release.

Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Next Gen Establishes its Second 100% owned Subsidiary, GreenRush Analytical Laboratories Inc.

Posted by AGORACOM-JC at 8:37 AM on Tuesday, May 6th, 2014

-GreenRush Analytical Labs (GAL) is a wholly owned Subsidiary of Next Gen

-The Mission of GreenRush Analytical Labs; is to provide analytical testing for the Legal Cannabis Industry in North America by delivering customized solutions and accurate analytical results to our clients.

-The Vision of GreenRush Analytical Labs; is to become a leading Laboratory company focused on servicing the legalized cannabis industry in North America.

-Proposed new Canadian Medical Marijuana and Industrial Hemp laws and regulations are anticipated to set additional standards for licensed producers that require more detailed Quality control and Quality assurances from Licensed Producers.

-Anticipated new legislation in the United States for medical/recreational Marijuana and Industrial Hemp can derive unprecedented growth in these new Multi-Billion Dollars industries

Vancouver, British Columbia, Canada-(May 6th, 2014) – Next Gen Metals Inc. (“Next Gen”, the “Company”) (CSE: N, OTC Pink: NXTTF, FSE: M5BN) is pleased to announce that it has established its second %100 owned subsidiary, GreenRush Analytical Laboratories Inc. (GAL). The Mission of GreenRush Analytical Laboratories Inc. is to provide analytical testing for the Legal Cannabis Industry in North America by delivering customized solutions and accurate analytical results to our clients.
Next Gen’s competitive advantages include:

  1. 1.Management’s financial contacts to raise venture capital
  2. 2.Management’s ability to efficiently manage both public and private companies on an

International scale

  1. 3.Management’s ability to negotiate equitable deals for our shareholders and partners
  2. 4.Management’s ability to Complete its objectives on time and on budget

GAL is organizing a team of scientists and laboratory technicians to staff our first Laboratory. Simultaneously GAL’s management continues to meet with targeted under-funded Analytical Laboratory opportunities for possible mergers and acquisitions.

With over 300 years of experience and managing public and private companies, negotiating complex deals and raising venture capital our Management team has completed over 300 option/joint venture agreements with major, mid-tier and junior companies and have raised over $250,000,000 in equity to advance projects across the world.

Harry Barr, President and CEO stated, “New laws and legislations in Canada and in the United States allow production of Legal/Medical Marijuana. An increasing number of U.S states have allowed Licensed Producers, to produce Medical Marijuana. Additionally, to date, two States have legalized Recreational Marijuana.

In Canada; new federal laws (April 1st 2014) allowed for Licensed Producers to establish new legal Marijuana grow up operations to produce Marijuana. To that end ,and as of today, there are currently thirteen Licensed Producers in Canada and over 650 applications in progress1.

This unpredicted growth in this new multi-billion dollars industry has allowed the directors and management of Next Gen to provide an increasing number of financial solutions for the Medical Marijuana and Industrial Hemp industries.”

Management is currently in the process of assessing and selecting initial locations and jurisdictions to establish the laboratories. Management’s objective is to initiate analytical laboratories in areas with the greatest concentration of Licensed Producers in both the legal Medical Marijuana and Industrial Hemp industries.

Market Demand

Under the new MMPR program, companies that wish to grow and sell medical marijuana must follow a strict set of rules, including quality control and data keeping protocols.

For example, each batch of cannabis must be tested for pesticides, mold and contaminants, in addition to chemical composition, before being sold2.

New standards for quality control and quality assurance in the USA and in Canada are deriving increased demand for these analytical tests and procedures. Three main purposes for Medical Cannabis and Industrial

Hemp testing are:

  1. 1.Health Canada requirements
  2. 2.Patient and consumer safety
  3. 3.Limiting liability for Licensed Producers

Market Size
Health Canada estimates that the market could be worth $1.3 billion by 2024. Analysts and industry experts peg estimates to be closer to $2.6 billion by 2016.

The medical community, health givers and patients demanding product testing to understand the safety and the strength of a particular product, and find the best medicine to alleviate their particular ailments.

In light of Next Gen’s vision and having completed our first two investments, Management’s objective is to invest in a basket of company’s within this growing industry. The company’s business model continues to generate new business plans and project submittals 24/7.

About GreenRush Financial Conferences

GreenRush Conferences shares a similar vision as its sole shareholder Next Gen (PubCo, CSE: N, OTC Pink: NXTTF, FSE: M5BN): a vision to provide a forum for venture capital investment, education, business to business opportunities as well as act as a facilitator for this emerging industry.

The conference will feature insightful speakers, government, health and industry specialists, public and private companies, fund managers, bankers, brokers, analysts, and media who share a common interest in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. GreenRush Conferences will be tailored to institutional, high net worth and retail investors with a focus on education and investment in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors.

The first conference will held in Vancouver, British Columbia on Wednesday May 7th, 2014 at the Vancouver Convention and Exhibition Centre East, Ballrooms A/B/C in the Pan Pacific Hotel. The company is planning a second conference to be held in Toronto, Conference Centre, Ontario on June 26th, 2014 at Toronto’s Conference Centre. Further conferences are also slated for other cities in Canada and the United States and Europe.

For more information on GreenRush Conferences please visit our website at www.greenrushfinancialconferences.com, email us at [email protected] or contact us by phone at (604) 685-1870.
About Next Gen

(CSE: N, OTC Pink: NXTTF, FSE: M5BN)
Next Gen is a diversified Canadian public company which focuses on investing in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. Recent regulatory/legal changes in North America have provided an opportunity for the company to enter into this emerging multi-billion dollar industry.
Next Gen’s vision is to be the leading provider of venture capital, management expertise, education and a facilitator for this explosive new industry.

Our business model generates dozens of new business plans and industry related proposals on an ongoing basis. Management continues to receive and review the proposals from various segments of the industry including: alternative medicine, health, food, agri-business, legal grow-ops, technology, client generation, education, public awareness, specialty clinics and ancillary business opportunities. For further information, visit our website at www.nextgenmetalsinc.com.

On March 20, 2014, Next Gen Metals announce that it has established its first wholly owned subsidiary, a Conference Division, that intends to host Canada’s first conferences focused on business to business opportunities, investment and education in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors.

On May 6th, 2014 Next Gen announced the establishment of its second wholly owned subsidiary GreenRush Analytical Laboratories Inc. GreenRush Analytical Laboratories Inc. will provide analytical testing to the cannabis industry by delivering customized solutions and accurate analytical results and ensure the health and safety of consumers. GreenRush Analytical Laboratories Inc. would be dedicated to helping physicians and health care providers improve patient health.

In light of Next Gen’s vision, Management’s intention is to invest in a basket of companies within this growing industry. The company’s business model continues to generate new business plans and project submittals 24/7.
For further information on GreenRush Analytical Laboratories Inc. please visit us at www.nextgenmetalsinc.com

On behalf of the Board of Directors

“Harry Barr”

Harry Barr

President & CEO

FORWARD LOOKING INFORMATION

This News Release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements.

Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This News Release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this News Release

Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Industrial Hemp and Medical Marijuana Industry Gather for GreenRush Financial Conference in Vancouver

Posted by AGORACOM-JC at 10:58 AM on Monday, May 5th, 2014

Next Gen Subsidiary Announces First of Global Series of Industry, Finance and Investment Conferences

VANCOUVER,B.C., May 5, 2014 (GLOBE NEWSWIRE) — A hundred and fifty years ago, Harry Barr’s (President and CEO of Next Gen Metals) (CSE:N) (OTC Pink:NXTTF), ancestors began farming in the Ottawa Valley. As far back as pre WWII, the family farm was producing hemp, which in those days was used primarily for rope for the War Act.

At 23, a young Harry Barr graduated from the University of Guelph in Agribusiness and began a career that forged him into a global mining executive and financier. Barr notes that since 1985, every exploration company he has started is still in business today and managed from Vancouver.

Now, Barr’s company has seized the opportunity to incubate and mentor those legal marijuana and hemp companies that have the technical savvy, but require the business acumen that any new or expanding industry needs; be it fundraising, complex negotiation skills, capital markets expertise, public company administration or IPO’s.

Those tenets will take shape in a big way on May 7th, when Next Gen’s 100 percent-owned subsidiary, GreenRush Financial Conferences launches in Vancouver at the Convention Centre East and the Pan Pacific Hotel with the first of a series of global Medical Marijuana and Industrial Hemp conferences, bringing together stakeholders, investors, companies and the legal community. Simply put, these conferences intend to be the premier purveyor of investment education and finance for the Medical Marijuana, Industrial Hemp and Alternative Medicine industries.

“I applaud Mr. Barr for being a pioneer and recognizing the lack of Marijuana expositions in Canada that focus on finance,” stated Mike Withrow, President and CEO of Abattis Bioceuticals Corp (OTC PINK:ATTBF). “We now have a forum to tell the world about our Grow Dry Extract Refine and Sciences model coined GDERS.”

“The Medical Marijuana business is slowly recapitalizing the junior mining industry in Canada,” stated Harry Barr, CEO of Next Gen. “But more than that, it is quickly bringing together the legal and industry forces necessary to give a complex, highly regulated market the visibility and transparency that investors require.”

Barr’s quote that the Medical Marijuana Industry is recapitalizing junior mining is a result of the fact that Canadian Securities Laws have allowed for thousands of Venture Capital companies to be formed. Given the mining downturn of the last three years, many of these entrepreneurs with proven fund raising and capital market abilities are now taking their shareholders into this new multibillion-dollar industry.

As well as discussing direct investment opportunities, the GreenRush Conferences will focus on the latest Medical Marijuana research, legal issues and give an overview of the industrial hemp market and the role of Alternative Medicines.

There is little chance that growth in this space will retreat anytime soon. The majority of support for the legalization exceeds 50% in Boomers and hits 65% for Millennials. From 1969 to 2013, legalization of marijuana supporters grew from 12% to 52%. Those wanting it to remain illegal dropped from 84% to 45% in the same period.

Barr was an early adopter who, using mining parlance, staked his claim in the Medical Marijuana space well before most others. Unlike some juniors, from Day One, his approach was not knee-jerk opportunism, but a well thought out business strategy utilizing decades of business acumen to add consistent shareholder value.

Management of Next Gen (as well as other entrepreneurs) is very good at raising capital. The Company intends to extend its brand to this industry and is actively seeking and reviewing new business plans. It intends to be a leader in the space and the go-to Company for legal marijuana and industrial hemp investments.

Barr is also the driving force of the International Metals Group (IMG), a brain bank of project acquisition, exploration and development professionals, including dedicated CEOs, geologists, engineers, corporate finance and investor relations experts, corporate managers, public company administrators, and regulatory and government affairs specialists.

To date, IMG companies (past and present) have completed over 300 option/joint venture agreements with major, mid-tier and junior companies and raised over $250,000,000 to advance their projects throughout 9 countries.

Barr could well be right in his assumptions, being a fixture on the mining scene for 29 years. As CEO, Chairman and Director of Pacific North West Capital Corp, he is also Chairman and CEO of El Nino Ventures, President of Next Gen Minerals (CSE:N) (OTC Pink: NXTTF) and Chairman of Southern Sun Minerals. Pacific North West Capital Corp is a controlling shareholder of Next Gen (22%), approximately 10% of El Nino Ventures and has a modest but important stake in Southern Sun Minerals.

Barr is not abandoning his mining roots and projects. In Ontario, Barr’s Pacific Northwest Capital made a grass roots discovery on its River Valley Platinum Group metal property, which is now a multi-million ounce deposit. The Group’s mining team is working hard to joint venture this advanced stage project with a company capable of financing this project to production.

As well, in Bathurst, New Brunswick, Mr. Barr’s El Nino Venture’s has two option agreements with Glencore Canada and Brazil’s second largest mining company Votorantim. Earlier this year El Nino won a five-year international arbitration on its D.R.C. copper discovery freeing up this project for continued development.

The GreenRush Financial Conference Exhibitor Space opens at 7:00 am; the opening talk is at 8:00am and concludes at 6:pm on May 7th at the Vancouver Convention Centre East and Ballrooms A/B/C/ in the Pan Pacific Hotel. The final hour hosts a discussion entitled; “The Great Debate: Legalization versus Prohibition,” followed by drinks and informal networking and discussion.

As well as an impressive lineup of speakers, there is an exhibitor hall with representatives from the Medical Marijuana community, investment dealers, financial professionals, media and the legal profession. Investors, media and other interested individuals can register through the conference site at www.greenrushfinancialconferences.com.

Of the more than two-dozen speakers are Bruce Linton from Tweed Marijuana (TSX-V:TWD), Harry Barr from Next Gen Metals, Chris Bunka from Lexaria Corp (OTCQB:LXRP), Craig Goodwin of Naturally Splendid (TSX-V:NSP), John Conroy of Conroy & Company and Daniel L. Kiselbach from Deloitte.

While the Medical Marijuana market represents a unique investment opportunity, it is important for investors to arm themselves with the facts in this complex, burgeoning market. Highly regulated, the companies that do the stringent due diligence necessary and develop the most growth-oriented alliances and partnerships will undoubtedly be the names that rise to the top as the space matures and garners increasing investor interest.                                                                                                                             

Legal Disclaimer/Disclosure: A fee has been paid for the production and distribution of this Report. This document is not and should not be construed as an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. No information in this article should be construed as individualized investment advice. A licensed financial advisor should be consulted prior to making any investment decision. Financial Press makes no guarantee, representation or warranty and accepts no responsibility or liability as to its accuracy or completeness. Expressions of opinion are those of the author’s only and are subject to change without notice. Financial Press assumes no warranty, liability or guarantee for the current relevance, correctness or completeness of any information provided within this article and will not be held liable for the consequence of reliance upon any opinion or statement contained herein or any omission. Furthermore, we assume no liability for any direct or indirect loss or damage or, in particular, for lost profit, which you may incur as a result of the use and existence of the information, provided within this article.

Also, please note that republishing of this article in its entirety is permitted as long as attribution and a back link to FinancialPress.com are provided. Thank you.

CONTACT: 650 - 555 West 12th Avenue, City Square, West Tower
         Vancouver, B.C. V5Z 3X7 Canada
         Telephone: 604.685.1870 Facsimile: 604.685.8045
Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana 
Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Canada’s First Medical Marijuana, Industrial Hemp and Alternative Medicine Investment Conference – May 7th in Vancouver

Posted by AGORACOM-JC at 11:43 AM on Friday, May 2nd, 2014

GreenRush Financial Conferences is a wholly owned subsidiary of Next Gen (PubCo, CSE: N, OTC Pink: NXTTF, FSE: M5BN). GreenRush’s vision is to be the premier purveyor of investment conferences for the Medical Marijuana, Industrial Hemp and Alternative Medicine industries.

The conference will feature insightful speakers, government, health and industry specialists, public and private companies, fund managers, bankers, brokers, analysts, and media who share a common interest in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. GreenRush Conferences will be tailored to institutional, high net worth and retail investors with a focus on education and investment in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors.

Interview  Article   Article  Interview  Video Video

Speaker and Exhibitor Lineup – May 7th Vancouver Conference

VancouverGreenRush Financial Conference
May 7, 2014 7:00 a.m. – 5:00 p.m.
Vancouver Convention Centre East, Ballrooms A/B/C

 CLICK HERE TO REGISTER

Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Harry Barr Discusses Upcoming Medical Marijuana Conference – May 7, 2014 in Vancouver

Posted by AGORACOM-JC at 3:22 PM on Tuesday, April 29th, 2014

GreenRush Financial Conferences is a wholly owned subsidiary of Next Gen (PubCo, CSE: N, OTC Pink: NXTTF, FSE: M5BN). GreenRush’s vision is to be the premier purveyor of investment conferences for the Medical Marijuana, Industrial Hemp and Alternative Medicine industries.

The conference will feature insightful speakers, government, health and industry specialists, public and private companies, fund managers, bankers, brokers, analysts, and media who share a common interest in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. GreenRush Conferences will be tailored to institutional, high net worth and retail investors with a focus on education and investment in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors.

Speaker and Exhibitor Lineup – May 7th Vancouver Conference

Vancouver Convention Centre East
Ballrooms A/B/C in the Pan Pacific Hotel
May 7, 2014 7:30 a.m. – 6:00 p.m.

 Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Creator of Charlotte’s Web marijuana strain says Canada legislation is archaic

Posted by AGORACOM-JC at 2:18 PM on Tuesday, April 29th, 2014
CTVNews.ca Staff
Published Tuesday, April 29, 2014 11:14AM EDT

The developer of a special strain of marijuana marketed to children hopes to convince Health Canadato allow the product in the country, as some Canadian families head south of the border to receive the drug that’s been shown to significantly reduce seizures.

Colorado cannabis producer Josh Stanley and his brothers developed Charlotte’s Web — a special strain of marijuana oil with very little THC and very high cannabidiol (CBD), the component believed to reduce seizures.

The marijuana extract is designed not to produce a high, but instead fight seizures through its high level of anti-inflammatory properties.

Josh Stanley, the developer of a special strain of marijuana marketed to children, hopes to convince Health Canada to allow the product in the country.

The strain is named in honour of Charlotte Figi, a U.S. girl who was losing a lifelong battle to epilepsy until she began using the marijuana oil.

“When we had met Charlotte, unfortunately, her family had signed a do-not-resuscitate order,” Stanley told CTV’s Canada AM on Tuesday.

Charlotte was diagnosed with Dravet Syndrome, a rare and catastrophic form epilepsy that begins in infancy. Prior to testing the oil she was suffering from about 350 seizures a week.

Doctors had told the Figi family there were few options left for the youngster after the majority of anti-epileptic drugs had failed to work. Neurologists removed Charlotte from the drugs she had been prescribed. She began using the cannabis oil as an end of life comfort measure.

“Immediately after starting this all-natural, organic treatment, she went from 350 seizures to zero,” Stanley said. “And two-and-a-half years later she remains 97- per cent seizure-free.”

The marijuana extract is produced in Colorado, but state law does not allow the shipment or sale of marijuana products out-of-state.

Stanley said this has led to the creation of “medical refugees.” He said a number of families have moved to Colorado from throughout the U.S., and some from Canada, to receive the treatment.

“Kids come there and get the treatment, but then they become prisoners in Colorado,” he said. “They’re not able to leave the state.”

Since that winter of 2012 more than 180 pediatric epilepsy patients have started treatment. Stanley said “thousands” of others are on the waiting list, including some children from Canada.

Health Canada does not permit the sale of cannabis resins, oils, extractions and edible marijuana products. Only dry medical marijuana can be sold to clients.

Stanley described the medical marijuana legislation in Canada as “archaic.”

“Heath Canada seems to want to push kids to smoking, or people to smoking, because extracts are not allowed,” he said.

Stanley said the best way to change health officials’ minds about the marijuana oil is to “show them they have a problem.”

“What we’re talking about here is life or death for many of these children,” he said.

Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks